Hope in the Pipeline
Welcome to the third part of our Hope in the Pipeline series on hypersomnolence disorders. In this episode, we dive deep into: 🔹 Medications used to treat narcolepsy – from older stimulants to newer, longer-lasting options 🔹 The role of antidepressants and sodium oxybate in managing symptoms like cataplexy 🔹 Key differences between narcolepsy and idiopathic hypersomnia (IH) 🔹 Current treatment options for IH and why diagnosis can be so challenging 🔹 Exciting ongoing clinical research at Preferred Research Partners, including a new potential therapy targeting narcolepsy and IH
18 Folgen
Kommentare
0Sei die erste Person, die kommentiert
Melde dich jetzt an und werde Teil der Hope in the Pipeline-Community!